President Trump Nominates Dr. Heidi Overton to Lead FDA
President Trump has announced the nomination of Dr. Heidi Overton, a top White House aide and deputy director of the Domestic Policy Council, to lead the Food and Drug Administration (FDA). If confirmed by the Senate, Overton, who has been…
Detroit, MI, August 19, 2026 —
President Donald Trump has announced his nomination of Dr. Heidi Overton to serve as the next commissioner of the Food and Drug Administration (FDA). Dr. Overton currently holds the position of deputy director of the Domestic Policy Council and is described as a top White House aide.
The nomination is contingent upon confirmation by the U.S. Senate. Throughout her tenure, Dr. Overton has been recognized as a proponent of President Trump’s health-related policy initiatives.
Should she be confirmed, Dr. Overton would be stepping into a role that carries significant responsibilities. The agency faces a landscape of numerous challenges, including the need to balance competing priorities within its broad regulatory scope. Additionally, she would be tasked with addressing unfinished projects and initiatives that were underway during the tenure of the previous FDA head.
The previous FDA commissioner’s departure has left a number of projects pending, and the agency’s future direction under new leadership will be closely watched by industry stakeholders, public health advocates, and the public.
Further details regarding the confirmation process and Dr. Overton’s specific policy proposals are expected to emerge as the nomination proceeds through the Senate.
Story summarized from the original created by Ali Swenson, Associated Press on www.clickondetroit.com, see more information here.
